Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03161821 · ClinicalTrials.gov registry record
Circulating Tumor Cells in Solid Tumors
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 206
- Enrollment target
NCT03161821 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 206 participants.
The verdict
NCT03161821 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 206 participants
- Enrollment target
Study Summary
The purpose of this study is to identify circulating tumor cells in patients with solid tumors. Quantify and characterize these cells, collect patient information in regards to the patient's cancer. Develop a database and a sample repository where future analysis could be done.
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2011-12-09 |
| Est. Completion | 2021-02-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03161821
The ClinicalTrials.gov registry entry for NCT03161821 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT03161821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03161821 about?
NCT03161821 is a clinical study titled "Circulating Tumor Cells in Solid Tumors". The purpose of this study is to identify circulating tumor cells in patients with solid tumors. Quantify and characterize these cells, collect patient information in regards to the patient's cancer. Develop a database and a sample repository where future analysis could be done.
What is the current status of trial NCT03161821?
This trial is currently completed. The enrollment target is 206 participants. The study started on 2011-12-09. Estimated completion is 2021-02-16.
What interventions are being tested in trial NCT03161821?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT03161821?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.